Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. The specific aims of pharmacovigilance are to; improve patient care and safety in relation to the use of medicines and all medical and paramedical interventions, improve public health and safety in relation to the use of medicines, contribute to the assessment of benefit, harm, effectiveness and risk of medicines, encouraging their safe, rational and more effective (including cost-effective) use, and promote understanding, education and clinical training in pharmacovigilance and its effective communication to the public. Various methods in pharmacovigilance are passive surveillance, include spontaneous reporting and stimulated reporting, active surveillance by sentinel sites, drug event monitoring, registries, comparative observational studies by survey study, case control study, targeted clinical investigations by investigate drug-drug interactions and food- drug interactions. A number of national pharmacovigilance centres are now monitoring the safety of traditional medicines. For that to succeed, the collaboration and support of consumers, traditional health practitioners, providers of traditional and herbal medicines and other experts is necessary.
Pharmacovigilance is one of the most relevant issues in clinical toxicology and drug development so the journal focuses on this topic as well as releases recent clinical findings coming within the scope of pharmacovigilance and clinical trials.
Last date updated on November, 2020